<VariationArchive RecordType="classified" VariationID="959" VariationName="NG_009846.1:g.103171_225796del" VariationType="Deletion" Accession="VCV000000959" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-10-15" DateCreated="2016-10-14" MostRecentSubmission="2016-10-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="15998" VariationID="959">
      <GeneList>
        <Gene Symbol="LOC132090298" FullName="Neanderthal introgressed variant-containing enhancer experimental_39258" GeneID="132090298" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>15q13.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="27916571" stop="27916740" display_start="27916571" display_stop="27916740" Strand="+" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="15" Accession="NT_187660.1" start="50858" stop="51027" display_start="50858" display_stop="51027" Strand="+" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="15" Accession="NW_011332701.1" start="50858" stop="51027" display_start="50858" display_stop="51027" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC132090299" FullName="Neanderthal introgressed variant-containing enhancer experimental_39278" GeneID="132090299" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>15q13.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="27930825" stop="27930994" display_start="27930825" display_stop="27930994" Strand="+" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="15" Accession="NT_187660.1" start="65112" stop="65281" display_start="65112" display_stop="65281" Strand="+" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="15" Accession="NW_011332701.1" start="65112" stop="65281" display_start="65112" display_stop="65281" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="OCA2" FullName="OCA2 melanosomal transmembrane protein" GeneID="4948" HGNC_ID="HGNC:8101" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>15q12-13.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="27719008" stop="28099315" display_start="27719008" display_stop="28099315" Strand="-" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="15" Accession="NT_187660.1" start="5441" stop="233614" display_start="5441" display_stop="233614" Strand="-" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="15" Accession="NW_011332701.1" start="5441" stop="233614" display_start="5441" display_stop="233614" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="28000020" stop="28344457" display_start="28000020" display_stop="28344457" Strand="-" />
          </Location>
          <OMIM>611409</OMIM>
        </Gene>
      </GeneList>
      <Name>NG_009846.1:g.103171_225796del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>15q13.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="27878517" stop="28001142" display_start="27878517" display_stop="28001142" variantLength="122626" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="28123663" stop="28246288" display_start="28123663" display_stop="28246288" variantLength="122626" />
      </Location>
      <OtherNameList>
        <Name>122.5-KB DEL</Name>
      </OtherNameList>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009846.1" sequenceAccession="NG_009846" sequenceVersion="1" change="g.103171_225796del">
            <Expression>NG_009846.1:g.103171_225796del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000015.10" sequenceAccession="NC_000015" sequenceVersion="10" change="g.27878517_28001142del" Assembly="GRCh38">
            <Expression>NC_000015.10:g.27878517_28001142del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000015.9" sequenceAccession="NC_000015" sequenceVersion="9" change="g.28123663_28246288del" Assembly="GRCh37">
            <Expression>NC_000015.9:g.28123663_28246288del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="nssv1415023" DB="dbVar" />
        <XRef ID="nsv513795" DB="dbVar" />
        <XRef Type="Allelic variant" ID="611409.0008" DB="OMIM" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NG_009846.1:g.103171_225796del AND Tyrosinase-positive oculocutaneous albinism" Accession="RCV000001010" Version="4">
        <ClassifiedConditionList TraitSetID="250">
          <ClassifiedCondition DB="MedGen" ID="C0268495">Tyrosinase-positive oculocutaneous albinism</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2003-01-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2003-01-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2016-10-14" MostRecentSubmission="2016-10-14">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">12469324</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="250" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="198" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Tyrosinase-positive oculocutaneous albinism</ElementValue>
                <XRef ID="Oculocutaneous+albinism+type+2/5317" DB="Genetic Alliance" />
                <XRef ID="26336006" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Albinism 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Albinoidism</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">ALBINISM II</ElementValue>
                <XRef Type="MIM" ID="203200" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Albinism, oculocutaneous, type II</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">OCA2</ElementValue>
                <XRef Type="MIM" ID="203200" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="4038" />
                <XRef ID="4038" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">37053367</ID>
                <ID Source="BookShelf">NBK590568</ID>
              </Citation>
              <XRef ID="79432" DB="Orphanet" />
              <XRef ID="C0268495" DB="MedGen" />
              <XRef ID="MONDO:0008746" DB="MONDO" />
              <XRef Type="MIM" ID="203200" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="21160" SubmissionDate="2016-10-11" DateLastUpdated="2016-10-14" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="611409.0008_ALBINISM, OCULOCUTANEOUS, TYPE II" title="OCA2, 122.5-KB DEL_ALBINISM, OCULOCUTANEOUS, TYPE II" />
        <ClinVarAccession Accession="SCV000021160" DateUpdated="2016-10-14" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2003-01-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Yi et al. (2003) found a LINE-mediated 122.5-kb deletion of the OCA2 gene as the cause of frequently occurring oculocutaneous albinism type II (OCA2; 203200) among Navajo of northeastern Arizona. The deletion removed exons 10 through 20. Although it did not disrupt the reading frame of the gene, it removed 345 of the total 838 amino acids. The 12 transmembrane domains of the wildtype protein were reduced to 5. Sequence analysis of the breakpoints and the flanking sequences showed that both breakpoints were exactly end-joined and both were found within long interspersed nucleotide elements (LINEs). However, the breakpoint LINEs were oppositely oriented, and no sequence homology between them was found at the breakpoint juncture.</Attribute>
              <Citation>
                <ID Source="PubMed">12469324</ID>
              </Citation>
              <XRef DB="OMIM" ID="203200" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="OCA2" />
          </GeneList>
          <Name>OCA2, 122.5-KB DEL</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">122.5-KB DEL</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="611409.0008" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">ALBINISM, OCULOCUTANEOUS, TYPE II</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="21160" TraitType="Disease" MappingType="Name" MappingValue="ALBINISM, OCULOCUTANEOUS, TYPE II" MappingRef="Preferred">
        <MedGen CUI="C0268495" Name="Tyrosinase-positive oculocutaneous albinism" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

